<DOC>
	<DOC>NCT00455351</DOC>
	<brief_summary>Phase I study. Side-effects when combined with standard palliative radiotherapy.</brief_summary>
	<brief_title>Vorinostat and Palliative Radiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Pelvic Neoplasms</mesh_term>
	<mesh_term>Vorinostat</mesh_term>
	<mesh_term>Histone Deacetylase Inhibitors</mesh_term>
	<criteria>Pelvic malignancy Palliative radiation treatment planed ECOG &lt;3 Age&gt;18 years Previous pelvic radiotherapy Uncontrolled diarrhea Insulindependent diabetes mellitus BMI&lt;18.5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Palliative treatment</keyword>
	<keyword>Max. tolerable dose</keyword>
</DOC>